Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Read Article
News
2024
2023
Archive
Search news articles
September 15, 2022
IDEAYA Announces Pricing of Public Offering of Common Stock
September 15, 2022
IDEAYA Announces Proposed Public Offering of Common Stock
September 13, 2022
Novome Biotechnologies Raises $43.5 Million Series B Financing to Advance its Pipeline of Therapeutically Engineered Microbes
September 13, 2022
Akouos Receives FDA Clearance of its IND Application for AK-OTOF, a Gene Therapy Intended for the Treatment of OTOF-mediated Hearing Loss
September 13, 2022
Cidara Therapeutics Announces Initiation of Phase 2a Human Viral Challenge Trial to Evaluate CD388 for Universal Prevention of Influenza
September 12, 2022
Cabaletta Bio Presents New Interim Data from the DesCAARTes™ Phase 1 Trial at the 31st EADV Congress
September 12, 2022
IDEAYA Reports Positive Interim Phase 2 Clinical Results for Darovasertib and Crizotinib Synthetic Lethal Combination in Metastatic Uveal Melanoma
September 9, 2022
Nouscom Strengthens Leadership Team with the Appointments of Sven Gogov, MD, as Chief Medical Officer and Maria Arce-Tomas, PhD, as VP, Head of Regulatory Affairs
September 8, 2022
Purigen Biosystems Expands Commercial Presence in European Union with Proteigene Distribution Agreement
September 6, 2022
Homology Medicines Appoints Albert Seymour, Ph.D., Chief Executive Officer
« Previous Page
1
…
21
22
23
24
25
…
118
Next Page »